Acute Respiratory Infections (ARIs) are responsible for 4.25 million deaths annually and are the third largest cause of mortality in the world.1
Viral and bacterial respiratory illnesses often present with similar symptoms. Testing is often needed to differentiate between these illnesses to help clinicians diagnose and properly treat patients in a timely manner.
Our nasal swab test looks for 47 different pathogens’ DNA that are known to cause infection of the respiratory tract. Results are then sent to your primary care physician within 36 hours of the test which allows your primary care physician a timely and more accurate way to treat any infection. In turn this allows your physician to provide you with a more specific treatment for your condition.
Testing with this panel has concluded that more than 40% of patients that test positive for Flu or COVID19 virus also have a significant bacterial infection that requires treatment with antibiotics. Treating and getting rid of these harmful pathogens before or while being exposed to a viral infection should also allow the body to respond more effectively to treatment.
The test consists of a simple nasal swab performed in our office or curb-side by a trained health professional. The only out-of-pocket cost is the standard office visit fee at our office. Insurance is accepted and submitted by the laboratory.
Appointments are limited. Please call our office to schedule your screening appointment.
Clinical Advantages
- Prevents Delays in Diagnosis & Treatment (*24 hrs. Post Lab Arrival)
- Detects Polymicrobial Infections Simultaneously
- Unaffected by Concomitant Medications
- Reduces Unnecessary Drug Exposure and Adverse Events
- Decreases the Progression and Spread of Infection
- Provides Up-to-Date Regional Sensitivity & Susceptibility Patterns
- Improves Selection of Narrow-Spectrum Antibiotics
- Prepares Clinicians to Make Cost-Sensitive Treatment Decisions
Respira-ID™ Testing Menu
Viruses
- Adenovirus 1 & 2 Alpha
- Adenovirus 1 & 2 Beta
- COVID 19
- Coronavirus 229E
- Coronavirus HKU1
- Coronavirus NL63
- Coronavirus OC43
- Cytomegalovirus (HHV5)
- Enterovirus D68
- Epstein-Barr virus (HHV4)
- Human Bocavirus (HBoV)
- Human Herpesvirus (HHV6)
- Human Metapneumovirus
- Influenza A virus (Pan)
- Influenza A virus H1-2009
- Influenza A virus H3
- Influenza B virus
- Morbillivirus Measles
- MERS-CoV
- Epidemic Parotitis (Mumps)
- Parainfluenza 1
- Parainfluenza 2
- Parainfluenza 3
- Parainfluenza 4
- Parechovirus
- Respiratory Syncytial Virus A
- Respiratory Syncytial Virus B
- SARS-Coronavirus
- Varicella zoster virus (HHV3)
Bacteria
- Bordetella (PAN)
- Bordetella holmesii
- Bordetella pertussis
- Chlamydophila pneumoniae
- Coxiella burnetii
- Haemophilus influenzae
- Klebsiella pneumoniae
- Legionella pneumophila
- Moraxella catarrhalis
- Mycobacterium avium complex
- Mycoplasma pneumonia
- Pneumocystis jirovecii
- Pseudomonas aeruginosa
- Staphylococcus aureus
- Streptococcus agalactiae (group B)
- Streptococcus pneumoniae
- Streptococcus pyogens
Fungi
- Aspergillus fumigatus
1 Ferkol, Thomas & Schraufnagel, Dean (2013). The Global Burden of Respiratory Disease. ATS Journals, Vol. 11, No.3.
